ITGAX and diffuse large B-cell lymphoma: In the present study, we assessed the prognostic value of genes that encode lymphoid markers and built a risk score based on the expression of BCL2, BCL6, LAIR1, and CD11c. Our risk score allowed dividing patients with DLBCL in four risk groups (low risk, intermediate risk, and high risk).